News

Featured News

  • 2025 |
  • 2024 |
  • 2023 |
  • 2022 |
  • 2021 |
  • 2020 |
  • 2019 |
  • 2018 |
  • 2017 |
  • View All
  • Press Release | June 17, 2025

    Skyhawk Therapeutics Announces First Patient Dosed in Phase 2/3 FALCON-HD Trial of SKY-0515 for Huntington’s Disease

    Read More

    Press Release | May 28, 2025

    Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping

    Read More

    Press Release | May 27, 2025

    GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases

    Read More

    Press Release | May 22, 2025

    ImCheck Reports High Remission Rates in AML Patients with ICT01 Combination Therapy at ASCO 2025

    Read More